title: Hormone replacement therapy in menopausal women: risk factor or protection to nonalcoholic fatty liver disease?
authors.forename: Gesira
authors.initials: G
authors.lastname: Florentino
authors.forename: Helma P
authors.initials: HP
authors.lastname: Cotrim
authors.forename: André
authors.initials: A
authors.lastname: Florentino
authors.forename: Consuelo
authors.initials: C
authors.lastname: Padilha
authors.forename: Manoel
authors.initials: M
authors.lastname: Medeiros-Neto
authors.forename: Gerson
authors.initials: G
authors.lastname: Bragagnol
authors.forename: Paulo
authors.initials: P
authors.lastname: Schwingel
mesh_terms: D000368:Aged; D015914:Estrogen Replacement Therapy / Q000009:adverse effects*; D005234:Fatty Liver / Q000453:epidemiology* / Q000517:prevention & control*; D005260:Female; D006801:Humans; D007333:Insulin Resistance; D024821:Metabolic Syndrome / Q000453:epidemiology; D008875:Middle Aged; D065626:Non-alcoholic Fatty Liver Disease; D015995:Prevalence; D012189:Retrospective Studies; D012307:Risk Factors